MobiHealth News May 26, 2022
The London-based company most recently raised £5 million in Series A funding in 2020.
Patient data capture and clinical trial tech company uMotif announced Wednesday it had secured $25.5 million from a fund managed by Athyrium Capital Management.
The London-based firm raised £5 million in a Series A funding in 2020 and £2.4 million in 2018.
WHAT IT DOEs
uMotif makes software for gathering patient data for clinical trials and research, including decentralized studies. Its offerings include tools for obtaining consent, for electronic clinical outcome assessments (eCOA), for electronic patient-reported outcomes (ePRO) and eDiaries, and for capturing symptom information and wearable data.
WHAT IT’S FOR
The company will use the capital to scale and develop its platform and continue its...
Today's Sponsors
Today's Sponsor